{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:18:01Z","timestamp":1790518681134,"version":"4.1.0"},"reference-count":37,"publisher":"BMJ","issue":"10","funder":[{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The semantic variant of primary progressive aphasia (svPPA) is typically associated with frontotemporal lobar degeneration (FTLD) with longTAR DNA-binding protein (TDP)-43-positive neuropil threads and dystrophic neurites (type C), and is only rarely due to a primary tauopathy or Alzheimer\u2019s disease. We undertook this study to investigate the localisation and magnitude of the presumed tau Positron Emission Tomography (PET) tracer [<jats:sup>18<\/jats:sup>F]Flortaucipir (FTP; also known as T807 or AV1451) in patients with svPPA, hypothesising that most patients would not show tracer uptake different from controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>FTP and [<jats:sup>11<\/jats:sup>C]Pittsburgh compound B PET imaging as well as MRI were performed in seven patients with svPPA and in 20 controls. FTP signal was analysed by visual inspection and by quantitative comparison to controls, with and without partial volume correction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>All seven patients showed elevated FTP uptake in the anterior temporal lobe with a leftward asymmetry that was not observed in healthy controls. This elevated FTP signal, largely co-localised with atrophy, was evident on both visual inspection and quantitative cortical surface-based analysis. Five patients were amyloid negative, one was amyloid positive and one has an unknown amyloid status.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this series of patients with clinical profiles, structural MRI and amyloid PET imaging typical for svPPA, FTP signal was unexpectedly elevated with a spatial pattern localised to areas of atrophy. This raises questions about the possible off-target binding of this tracer to non-tau molecules associated with neurodegeneration. Further investigation with autopsy analysis will help illuminate the binding target(s) of FTP in cases of suspected FTLD-TDP neuropathology.<\/jats:p><\/jats:sec>","DOI":"10.1136\/jnnp-2017-316409","type":"journal-article","created":{"date-parts":[[2017,10,7]],"date-time":"2017-10-07T00:50:17Z","timestamp":1507337417000},"page":"1024-1031","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":95,"title":["Flortaucipir tau PET imaging in semantic variant primary progressive aphasia"],"prefix":"10.1136","volume":"89","author":[{"given":"Sara J","family":"Makaretz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Quimby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Makris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"McGinnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Vasdev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford C","family":"Dickerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,10,6]]},"reference":[{"key":"2020050722281760000_89.10.1024.1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww313"},{"key":"2020050722281760000_89.10.1024.2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31821103e6"},{"key":"2020050722281760000_89.10.1024.3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMcpc1613459","article-title":"Case 1-2017. A 70-Year-Old Woman with gradually progressive loss of language","volume":"376","author":"Mesulam","year":"2017","journal-title":"N Engl J Med"},{"key":"2020050722281760000_89.10.1024.4","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/115.6.1783"},{"key":"2020050722281760000_89.10.1024.5","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-011-0845-8"},{"key":"2020050722281760000_89.10.1024.6","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-008-0460-5"},{"key":"2020050722281760000_89.10.1024.7","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm213"},{"key":"2020050722281760000_89.10.1024.8","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp248"},{"key":"2020050722281760000_89.10.1024.9","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-306948"},{"key":"2020050722281760000_89.10.1024.10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/ana.24885","article-title":"Typical and atypical pathology in primary progressive aphasia variants","volume":"81","author":"Spinelli","year":"2017","journal-title":"Ann Neurol"},{"key":"2020050722281760000_89.10.1024.11","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww163"},{"key":"2020050722281760000_89.10.1024.12","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00401-016-1618-1","article-title":"[18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration","volume":"132","author":"Josephs","year":"2016","journal-title":"Acta Neuropathol"},{"key":"2020050722281760000_89.10.1024.13","first-page":"0271678X1668369","article-title":"Positron emission tomography imaging of tau pathology in progressive supranuclear palsy","volume":"271678X","author":"Coakeley","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"key":"2020050722281760000_89.10.1024.14","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24517"},{"key":"2020050722281760000_89.10.1024.15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ana.24844","article-title":"Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies","volume":"81","author":"Marqui\u00e9","year":"2017","journal-title":"Ann Neurol"},{"key":"2020050722281760000_89.10.1024.16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40478-016-0315-6","article-title":"An autoradiographic evaluation of AV-1451 Tau PET in dementia","volume":"4","author":"Lowe","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"2020050722281760000_89.10.1024.17","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jalz.2016.01.003","article-title":"Characterization of tau positron emission tomography tracer [(18)F]AV-1451 binding to postmortem tissue in Alzheimer\u2019s disease,\u00a0primary tauopathies, and other dementias","volume":"12","author":"Sander","year":"2016","journal-title":"Alzheimers Dement"},{"key":"2020050722281760000_89.10.1024.18","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww027"},{"key":"2020050722281760000_89.10.1024.19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jamaneurol.2016.5755","article-title":"Association of In Vivo [18F]AV-1451 tau PET Imaging results with cortical atrophy and symptoms in typical and atypical alzheimer disease","volume":"74","author":"Xia","year":"2017","journal-title":"JAMA Neurol"},{"key":"2020050722281760000_89.10.1024.20","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181ea15e8"},{"key":"2020050722281760000_89.10.1024.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra022435"},{"key":"2020050722281760000_89.10.1024.22","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000431"},{"key":"2020050722281760000_89.10.1024.23","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhg087"},{"key":"2020050722281760000_89.10.1024.24","doi-asserted-by":"crossref","unstructured":"Shoup TM , Yokell DL , Rice PA , et al . A concise radiosynthesis of the tau radiopharmaceutical, [18F]T807. J Label Compd Radiopharm 2013.","DOI":"10.1002\/jlcr.3098"},{"key":"2020050722281760000_89.10.1024.25","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.175273"},{"key":"2020050722281760000_89.10.1024.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2016.02.042"},{"key":"2020050722281760000_89.10.1024.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2006.01.021"},{"key":"2020050722281760000_89.10.1024.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropsychologia.2009.04.011"},{"key":"2020050722281760000_89.10.1024.29","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24546"},{"key":"2020050722281760000_89.10.1024.30","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.170027"},{"key":"2020050722281760000_89.10.1024.31","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-013-1089-6"},{"key":"2020050722281760000_89.10.1024.32","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-012-1055-8"},{"key":"2020050722281760000_89.10.1024.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2016.01.028"},{"key":"2020050722281760000_89.10.1024.34","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jamaneurol.2016.3338","article-title":"Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases","volume":"73","author":"Gomperts","year":"2016","journal-title":"JAMA Neurol"},{"key":"2020050722281760000_89.10.1024.35","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0b013e31824a7df4"},{"key":"2020050722281760000_89.10.1024.36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-017-0253-y","article-title":"Monoamine oxidase B inhibitor, selegiline, reduces (18)F-THK5351 uptake in the human brain","volume":"9","author":"Ng","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"2020050722281760000_89.10.1024.37","doi-asserted-by":"publisher","DOI":"10.1038\/srep16404"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2017-316409","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T18:08:49Z","timestamp":1601057329000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2017-316409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,6]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,9,13]]},"published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1136\/jnnp-2017-316409"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2017-316409","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,6]]}}}